Colesevelam Hydrochloride Powder, For Suspension while Breastfeeding

Do you know that important immune protective proteins are present in breast milk? Breast milk also contains required vitamins, minerals, saturated and un saturated fats. These things are extremely important for development of healthy brain. If you are taking any medicine for short term or for the chronic reason then that passes in breast milk as well, that is why you should always check the drug with your health care provider. Here at DrLact we try to analyze drugs based on available researches and in this sheet we will present our analysis for Colesevelam Hydrochloride Powder, For Suspension.

Colesevelam hydrochloride for oral suspension is a bile acid sequestrant indicated as an adjunct to diet and exercise to: •reduce elevated low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia (1.1). •reduce LDL-C levels in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia (HeFH) (1.1). Limitations of Use (1.3): •Do not use for treatment of type 1 diabetes or for diabetic ketoacidosis. •The effect on cardiovascular morbidity and mortality has not been determined. •Not studied in Fredrickson Type I, III, IV, and V dyslipidemias. •Not studied in children less than 10 years of age or in pre-menarchal girls. 1.1 Primary Hyperlipidemia Colesevelam hydrochloride for oral suspension is indicated as an adjunct to diet and exercise to reduce elevated low-density lipoprotein cholesterol (LDL-C) in adults with primary hyperlipidemia. Colesevelam hydrochloride for oral suspension is indicated to reduce LDL-C levels in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia (HeFH) who are unable to reach LDL-C target levels despite an adequate trial of dietary therapy and lifestyle modification. 1.3 Limitations of Use • Colesevelam hydrochloride for oral suspension should not be used for the treatment of type 1 diabetes or for the treatment of diabetic ketoacidosis. • The effect of colesevelam hydrochloride for oral suspension on cardiovascular morbidity and mortality has not been determined. • Colesevelam hydrochloride for oral suspension has not been studied in Fredrickson Type I, III, IV, and V dyslipidemias. • Colesevelam hydrochloride for oral suspension has not been studied in children younger than 10 years of age or in pre-menarchal girls.